
Page Contents
Neuro Matrix review summary
This review examines the older Neuro Matrix formula recorded in our archive. Its specific focus is a B12/Bacopa/PS base with small additional mushroom and cholinergic entries. The historical label and analysis below are not a claim that every current bottle has this composition, and this review does not infer that the product has been discontinued.
Formula analysis: A B12/Bacopa/PS base with small additional mushroom and cholinergic entries
The Neuro Matrix archive recorded B12 500 micrograms, Bacopa 300 mg, a 20% PS material 100 mg, ginkgo 100 mg, rhodiola 50 mg and DMAE 50 mg, with lion’s mane mycelium 50 mg, ALCAR 25 mg and huperzine A 10 micrograms. The additional entries distinguish it from shorter formulas using a similar base.
Those additions do not by themselves establish a more complete cognitive effect. A mushroom mycelium amount cannot be equated to a trial using another preparation, and a microgram huperzine amount must remain distinct from milligram botanical quantities. The PS material may yield about 20 mg active PS if the percentage describes the listed material.
The earlier review assigned likely memory, clarity and focus outcomes to the whole formula without a product trial. Ingredient roles cannot reliably predict which of those outcomes a user will experience, and a low price does not settle clinical usefulness.

Archived ingredient table
The following is the original article’s historical transcription. Serving amounts, percentages, spelling and ingredient descriptions may reflect an older label or transcription errors. It is retained for formula comparison, not as current-use instructions. Historical Daily Values are not recalculated here.
Neuro Matrix Ingredients | |
| Ingredients | Amount Per Serving |
| Vitamin B12 (as Cyanocobalamin) | 500 mcg (20,833% DV) |
| Bacopa Herb Extract | 300 mg |
| Phosphatidylserine 20% | 100 mg |
| Ginkgo Leaf Extract | 100 mg |
| Rhodiola Root Extract | 50 mg |
| Dimethylaminoethanol [DMAE] Bitartrate | 50 mg |
| Hericium Erinaceus Mycelium (Lion’s Mane) | 50 mg |
| Acetyl-L-Carnitine (as Acetyl-L-Carnitine HCl) | 25 mg |
| Huperzine A (from Toothed Club Moss Aerial Part Extract) | 10 mcg |

Safety and suitability
Huperzine A and ginkgo introduce medication considerations even though the list contains familiar nutritional names. Do not stack additional cholinergic products merely to compensate for a presumed weakness in one endpoint.
What the evidence does not establish
Ingredient studies, manufacturer descriptions and customer reviews cannot demonstrate the effect of this complete formula. We have not established a controlled clinical trial of this exact archived formulation in this review. No hands-on testing, clinical credentials or laboratory verification by Nootropic Geek are claimed.
Verdict on the recorded formula
The archived label gives enough information to identify its formula family and extra ingredients, but not to establish a broad memory/clarity/focus benefit. The useful comparison is preparation and active amount, not the number of brain-health claims.
Historical prices, stock statements and refund or subscription terms have been removed because they are not verified current offers. Before comparing value, establish the exact current formula, serving size and total purchase terms.
Original product and article images
These images document the version discussed in the original article and may not depict current packaging.

Related ingredient and comparison guides
- Phosphatidylserine Review: Memory Evidence and FDA Claim Limits
- Huperzine A Review: Cholinesterase Inhibition and Mixed Evidence
- Acetyl-L-Carnitine Review: Cognitive Trials and Metabolic Context
Sources
- Original Nootropic Geek article snapshot: historical formula transcription and previous review context; not a current manufacturer label.
- Explains that FDA does not approve qualified health-claim petitions; enforcement discretion reflects evidence limitations.
- FDA inventory identifies PS cognitive-function/dementia claim letters.
- Primary 210-participant phase II trial; prespecified primary endpoint did not demonstrate efficacy.
- NIH carnitine physiology, forms, cognition evidence and adverse effects.
Nootropic Geek is an affiliate publishing brand. This is an editorial review, not individual medical advice. About Nootropic Geek.


